Search Results 4431-4440 of 25533 for oral

  1. Oral Cavity & Pharynx. 8.0. 2.8. Adults aged 50-75 years who reported. State. Cervix. 5.9. 0.0. Esophagus. 5.2. 6.6 being up-to-date with colorectal cancer ...

  2. Oral Cavity & Pharynx. Uncategorized. 3.0. 1.9 being up-to-date with colorectal cancer screening. 0.8. 1.9. Target. 76.6%. 74.4%. 0.0. 0.0. Data Sources: ...

  3. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  4. A Study to Evaluate HKI-272 and Capecitabine for HER2-Positive Breast Cancer and Brain Metastases - Mayo Clinic

    Neratinib is a recently discovered oral drug that may stop breast cancer cells from growing abnormally by inhibiting (or blocking) members of a family of ...

  5. Publications - Andrew J. Barkmeier, M.D. - Mayo Clinic

    Kadikoy H, Barkmeier A, Peck B, Carvounis PE. Persistent photopsia following course of oral voriconazole. J Ocul Pharmacol Ther. 2010 Aug; 26(4):387-8. View ...

  6. Publications - Andrew C. Storm, M.D. - Mayo Clinic

    Gastrojejunal Anastomosis Adenocarcinoma Occurring After Trans-Oral Revision for Weight Recurrence After Roux-en-Y Gastric Bypass. ACG Case Rep J. 2025 Jul ...

  7. Infectious Diseases A-Z: Prevent norovirus with good hand hygiene - Mayo Clinic News Network

    "Norovirus is spread fecal-oral, meaning, often by hands that have been in contact with stool. So it's important that people who are sick with a norovirus ...

  8. Head and neck cancers - Doctors and departments - Mayo Clinic

    Cancer Care at Mayo Clinic · Children's Center · Head and Neck Cancer Center · Neurosurgery · Oncology (Medical) · Oral and Maxillofacial Surgery · Otolaryngology ( ...

  9. Movement Disorders Clinical Trials - Mayo Clinic Research

    Secondary Objectives: Part 1: - To assess the pharmacokinetic (PK) profile of oral dosing of GZ/SAR4027671 in plasma when administered in early-stage ...

  10. Congenital Metabolic Disorder Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the safety and tolerability of oral monosaccharide (galactose and fucose) treatment in a small pilot group of congenital ...